002589 瑞康医药
已收盘 04-30 15:00:00
资讯
新帖
简况
瑞康医药(002589)2025年一季报简析:净利润减6.58%,盈利能力上升
证券之星 · 04-30
瑞康医药(002589)2025年一季报简析:净利润减6.58%,盈利能力上升
瑞康医药(002589)3月31日股东户数7.76万户,较上期减少3.32%
证券之星 · 04-30
瑞康医药(002589)3月31日股东户数7.76万户,较上期减少3.32%
【医药商业板块震荡拉升,老百姓涨停】医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。
金融界 · 04-30
【医药商业板块震荡拉升,老百姓涨停】医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。
图解瑞康医药一季报:第一季度单季净利润同比减6.58%
证券之星 · 04-29
图解瑞康医药一季报:第一季度单季净利润同比减6.58%
瑞康医药(002589.SZ)发布一季度业绩,归母净利润1417.11万元,同比下降6.58%
智通财经 · 04-29
瑞康医药(002589.SZ)发布一季度业绩,归母净利润1417.11万元,同比下降6.58%
瑞康医药:已回购0.70%公司股份 耗资约3165.35万元
中国财富通 · 03-05
瑞康医药:已回购0.70%公司股份 耗资约3165.35万元
瑞康医药高溢价收购高管亏损公司 既往扩张代价惨痛是否会重蹈历史覆辙?
新浪证券 · 02-28
瑞康医药高溢价收购高管亏损公司 既往扩张代价惨痛是否会重蹈历史覆辙?
【瑞康医药等新设合伙企业】公开资料显示,近日,威海众天财运营管理合伙企业成立,出资额4亿元,经营范围包含:企业管理;品牌管理;企业总部管理;企业管理咨询等。股权数据显示,该企业由瑞康医药等共同出资。
金融界 · 02-25
【瑞康医药等新设合伙企业】公开资料显示,近日,威海众天财运营管理合伙企业成立,出资额4亿元,经营范围包含:企业管理;品牌管理;企业总部管理;企业管理咨询等。股权数据显示,该企业由瑞康医药等共同出资。
瑞康医药最新公告:拟收购浙江衡玖76.01%股权
证券之星 · 02-21
瑞康医药最新公告:拟收购浙江衡玖76.01%股权
【瑞康医药:拟收购浙江衡玖76.01%股权】瑞康医药公告,公司下属子公司吉祥山(山东)医学科技有限公司拟以现金方式收购关联方烟台衡悦健康科技合伙企业(有限合伙)持有的浙江衡玖医疗器械有限责任公司76.01%股权,交易金额为1.51亿元。浙江衡玖整体估值为1.99亿元,交易完成后,浙江衡玖将成为瑞康医药的合并报表子公司。此次交易构成关联交易,但不构成重大资产重组。
金融界 · 02-21
【瑞康医药:拟收购浙江衡玖76.01%股权】瑞康医药公告,公司下属子公司吉祥山(山东)医学科技有限公司拟以现金方式收购关联方烟台衡悦健康科技合伙企业(有限合伙)持有的浙江衡玖医疗器械有限责任公司76.01%股权,交易金额为1.51亿元。浙江衡玖整体估值为1.99亿元,交易完成后,浙江衡玖将成为瑞康医药的合并报表子公司。此次交易构成关联交易,但不构成重大资产重组。
A股医药商业板块震荡走强,塞力医疗涨超7.5%,润达医疗涨近4%,国科恒泰、漱玉平民、瑞康医药、人民同泰等跟涨。
美港电讯 · 02-10
A股医药商业板块震荡走强,塞力医疗涨超7.5%,润达医疗涨近4%,国科恒泰、漱玉平民、瑞康医药、人民同泰等跟涨。
12月26日瑞康医药现1笔大宗交易 机构净买入202.12万元
证券之星 · 2024-12-26
12月26日瑞康医药现1笔大宗交易 机构净买入202.12万元
瑞康医药12月26日现1笔大宗交易 成交金额202.12万元
新浪证券-红岸工作室 · 2024-12-26
瑞康医药12月26日现1笔大宗交易 成交金额202.12万元
瑞康医药(002589)12月10日主力资金净卖出3262.28万元
证券之星 · 2024-12-11
瑞康医药(002589)12月10日主力资金净卖出3262.28万元
瑞康医药(002589)11月29日股东户数8.53万户,较上期减少2.88%
证券之星 · 2024-12-05
瑞康医药(002589)11月29日股东户数8.53万户,较上期减少2.88%
加载更多
公司概况
公司名称:
瑞康医药集团股份有限公司
所属行业:
批发业
上市日期:
2011-06-10
主营业务:
瑞康医药集团股份有限公司的主营业务包含药品、器械配送板块、体外诊断板块、数字医疗板块、医药物流板块、中医药板块五大业务板块。其主要产品和服务为药品和器械配送、体外诊断、数字医疗、医药物流、中医药。公司目前已发展成一家全国性药品、医疗器械流通行业的领军企业之一,在中国医药商业协会公布的最新一期医药流通企业销售排名第七。对医疗机构直销业务规模在全国民营医疗企业中处于领先地位,IVD业务规模在全国处于领先地位。
发行价格:
20.00
{"stockData":{"symbol":"002589","market":"SZ","secType":"STK","nameCN":"瑞康医药","latestPrice":2.95,"timestamp":1745996586000,"preClose":2.83,"halted":0,"volume":53461310,"delay":0,"changeRate":0.0424,"floatShares":1366000000,"shares":1505000000,"eps":0.0131,"marketStatus":"已收盘","change":0.12,"latestTime":"04-30 15:00:00","open":2.82,"high":3.03,"low":2.82,"amount":157000000,"amplitude":0.0742,"askPrice":2.96,"askSize":6800,"bidPrice":2.95,"bidSize":814,"shortable":0,"etf":0,"ttmEps":0.0131,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"adjPreClose":2.83,"symbolType":"stock","openAndCloseTimeList":[[1745976600000,1745983800000],[1745989200000,1745996400000]],"highLimit":3.11,"lowLimit":2.55,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1504710471,"isCdr":false,"pbRate":0.77,"roa":"--","peRate":225.19084,"roe":"0.26%","epsLYR":0.0137,"committee":-0.660263,"marketValue":4439000000,"turnoverRate":0.0391,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-05-06。","floatMarketCap":4028000000},"requestUrl":"/m/hq/s/002589","defaultTab":"news","newsList":[{"id":"2532001354","title":"瑞康医药(002589)2025年一季报简析:净利润减6.58%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2532001354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532001354?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:55","pubTimestamp":1746053733,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期瑞康医药发布2025年一季报。截至本报告期末,公司营业总收入17.57亿元,同比下降12.98%,归母净利润1417.11万元,同比下降6.58%。本报告期瑞康医药盈利能力上升,毛利率同比增幅14.98%,净利率同比增幅20.27%。去年的净利率为0.51%,算上全部成本后,公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100005540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589"],"gpt_icon":0},{"id":"2531086453","title":"瑞康医药(002589)3月31日股东户数7.76万户,较上期减少3.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531086453","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531086453?lang=zh_cn&edition=full","pubTime":"2025-04-30 17:51","pubTimestamp":1746006684,"startTime":"0","endTime":"0","summary":"证券之星消息,近日瑞康医药披露,截至2025年3月31日公司股东户数为7.76万户,较1月27日减少2663.0户,减幅为3.32%。在医药商业行业个股中,瑞康医药股东户数高于行业平均水平,截至3月31日,医药商业行业平均股东户数为4.1万户。从股价来看,2025年1月27日至2025年3月31日,瑞康医药区间涨幅为4.33%,在此期间股东户数减少2663.0户,减幅为3.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000036642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002589","BK0070","BK0132","BK0250","BK0197","BK0185"],"gpt_icon":0},{"id":"2531246771","title":"【医药商业板块震荡拉升,老百姓涨停】医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531246771","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531246771?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:06","pubTimestamp":1745993167,"startTime":"0","endTime":"0","summary":"医药商业板块震荡拉升,老百姓涨停,瑞康医药涨超5%,塞力医疗、南京医药、漱玉平民跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30140650037793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09939","BK0250","BK0197","BK0132","BK0070","159938","301017","002589","BK0077","BK0185","BK1574","BK0209","BK1161","600713","BK1515","603883","603716"],"gpt_icon":0},{"id":"2531798533","title":"图解瑞康医药一季报:第一季度单季净利润同比减6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531798533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531798533?lang=zh_cn&edition=full","pubTime":"2025-04-30 02:45","pubTimestamp":1745952356,"startTime":"0","endTime":"0","summary":"证券之星消息,瑞康医药2025年一季报显示,公司主营收入17.57亿元,同比下降12.98%;归母净利润1417.11万元,同比下降6.58%;扣非净利润1003.38万元,同比下降44.75%;负债率64.53%,投资收益523.3万元,财务费用4917.17万元,毛利率13.85%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000001675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589"],"gpt_icon":0},{"id":"2531752074","title":"瑞康医药(002589.SZ)发布一季度业绩,归母净利润1417.11万元,同比下降6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531752074","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531752074?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:24","pubTimestamp":1745940285,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞康医药(002589.SZ)发布2025年一季度报告,第一季度,公司实现营业收入17.57亿元,同比下降12.98%。归属于上市公司股东的净利润1417.11万元,同比下降6.58%。归属于上市公司股东的扣除非经常性损益的净利润1003.38万元,同比下降44.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002589"],"gpt_icon":0},{"id":"2517971789","title":"瑞康医药:已回购0.70%公司股份 耗资约3165.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517971789","media":"中国财富通","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517971789?lang=zh_cn&edition=full","pubTime":"2025-03-05 18:49","pubTimestamp":1741171759,"startTime":"0","endTime":"0","summary":"中国财富通3月5日 - 瑞康医药(002589)公告称,截至2月28日,公司通过股份回购专用证券账户以集中竞价方式回购公司股份1,051.1550万股,占公司目前总股本的0.70%,最高成交价3.08元/股,最低成交价2.93元/股,成交总金额3,165.3535万元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=FaBnPWhNNwI%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","BK0197","BK0132","BK0070","BK0185","002589","BK0077"],"gpt_icon":0},{"id":"2514604983","title":"瑞康医药高溢价收购高管亏损公司 既往扩张代价惨痛是否会重蹈历史覆辙?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514604983","media":"新浪证券","labels":["executive","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514604983?lang=zh_cn&edition=full","pubTime":"2025-02-28 11:16","pubTimestamp":1740712560,"startTime":"0","endTime":"0","summary":" 近日,瑞康医药发布公告,公司拟以1.51亿元现金收购关联方烟台衡悦持有的浙江衡玖76.01%股权,交易整体估值1.99亿元。 根据2023年8月30日披露的公告显示,公司及控股子公司连续十二个月累计发生案件的诉讼、仲裁金额合计为5.63亿元,占公司最近一期经审计净资产绝对值的比例高达10.42%。同时,由于公司未及时披露诉讼情况,瑞康医药还因此收到深交所监管函及山东证监局警示函。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-02-28/doc-inemzcmr2486974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","BK0185","BK0132","BK0077","BK0250","002589","BK0197"],"gpt_icon":0},{"id":"2514058586","title":"【瑞康医药等新设合伙企业】公开资料显示,近日,威海众天财运营管理合伙企业成立,出资额4亿元,经营范围包含:企业管理;品牌管理;企业总部管理;企业管理咨询等。股权数据显示,该企业由瑞康医药等共同出资。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514058586","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514058586?lang=zh_cn&edition=full","pubTime":"2025-02-25 14:40","pubTimestamp":1740465629,"startTime":"0","endTime":"0","summary":"公开资料显示,近日,威海众天财运营管理合伙企业成立,出资额4亿元,经营范围包含:企业管理;品牌管理;企业总部管理;企业管理咨询等。股权数据显示,该企业由瑞康医药等共同出资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25144048366089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","BK0185","BK0197","BK0250","BK0070","BK0132","002589"],"gpt_icon":0},{"id":"2513298792","title":"瑞康医药最新公告:拟收购浙江衡玖76.01%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2513298792","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513298792?lang=zh_cn&edition=full","pubTime":"2025-02-21 21:56","pubTimestamp":1740146176,"startTime":"0","endTime":"0","summary":"瑞康医药公告,公司下属子公司吉祥山(山东)医学科技有限公司拟以现金向关联方烟台衡悦收购浙江衡玖医疗器械有限责任公司76.01%股权,交易金额为1.51亿元。此次交易构成关联交易,不涉及重大资产重组。浙江衡玖的估值为1.99亿元。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022100043584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589","BK0070","BK0197","BK0250","BK0132","BK0185","BK0077"],"gpt_icon":0},{"id":"2513260433","title":"【瑞康医药:拟收购浙江衡玖76.01%股权】瑞康医药公告,公司下属子公司吉祥山(山东)医学科技有限公司拟以现金方式收购关联方烟台衡悦健康科技合伙企业(有限合伙)持有的浙江衡玖医疗器械有限责任公司76.01%股权,交易金额为1.51亿元。浙江衡玖整体估值为1.99亿元,交易完成后,浙江衡玖将成为瑞康医药的合并报表子公司。此次交易构成关联交易,但不构成重大资产重组。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513260433","media":"金融界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513260433?lang=zh_cn&edition=full","pubTime":"2025-02-21 21:20","pubTimestamp":1740144007,"startTime":"0","endTime":"0","summary":"瑞康医药公告,公司下属子公司吉祥山(山东)医学科技有限公司拟以现金方式收购关联方烟台衡悦健康科技合伙企业(有限合伙)持有的浙江衡玖医疗器械有限责任公司76.01%股权,交易金额为1.51亿元。浙江衡玖整体估值为1.99亿元,交易完成后,浙江衡玖将成为瑞康医药的合并报表子公司。此次交易构成关联交易,但不构成重大资产重组。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21212048319655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0197","BK1574","BK1100","159883","BK1222","BK1583","BK0132","BK0077","002589","BK0070","BK0250","09997","BK0185","09996"],"gpt_icon":0},{"id":"2510704370","title":"A股医药商业板块震荡走强,塞力医疗涨超7.5%,润达医疗涨近4%,国科恒泰、漱玉平民、瑞康医药、人民同泰等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510704370","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510704370?lang=zh_cn&edition=full","pubTime":"2025-02-10 10:16","pubTimestamp":1739153807,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603716","BK0209","301370","BK0077","BK1574","BK0132","BK0185","399300","159982","002589","301017","159938","BK0070","BK0197","BK0250","BK1161","09939","600829","BK1515","603108"],"gpt_icon":0},{"id":"2494832426","title":"12月26日瑞康医药现1笔大宗交易 机构净买入202.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494832426","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494832426?lang=zh_cn&edition=full","pubTime":"2024-12-26 17:01","pubTimestamp":1735203690,"startTime":"0","endTime":"0","summary":"证券之星消息,12月26日瑞康医药发生大宗交易,交易数据如下:大宗交易成交价格2.99元,成交67.6万股,成交金额202.12万元,买方营业部为机构专用,卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生1笔大宗交易,合计成交6760.0手。该股近期无解禁股上市。截至2024年12月26日收盘,瑞康医药报收于2.99元,下跌0.33%,换手率1.33%,成交量18.16万手,成交额5444.64万元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122600026282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0197","BK0185","BK0132","BK0077","002589","BK0250"],"gpt_icon":0},{"id":"2494183282","title":"瑞康医药12月26日现1笔大宗交易 成交金额202.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494183282","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494183282?lang=zh_cn&edition=full","pubTime":"2024-12-26 16:40","pubTimestamp":1735202400,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 12月26日,瑞康医药收跌0.33%,收盘价为2.99元,发生1笔大宗交易,合计成交量67.6万股,成交金额202.12万元。 第1笔成交价格为2.99元,成交67.60万股,成交金额202.12万元,溢价率为0.00%,买方营业部为机构专用,卖方营业部为中信证券股份有限公司上海分公司。 进一步统计,近3个月内该股累计发生1笔大宗交易,合计成交金额为202.12万元。该股近5个交易日累计下跌7.43%,主力资金合计净流出4130.14万元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:小浪快报","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-26/doc-ineauqst6813201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","BK0250","BK0132","BK0197","BK0077","BK0185","002589"],"gpt_icon":0},{"id":"2490991072","title":"瑞康医药(002589)12月10日主力资金净卖出3262.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490991072","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490991072?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:19","pubTimestamp":1733879952,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月10日收盘,瑞康医药报收于3.33元,下跌2.06%,换手率4.43%,成交量60.52万手,成交额2.06亿元。12月10日的资金流向数据方面,主力资金净流出3262.28万元,占总成交额15.87%,游资资金净流入578.78万元,占总成交额2.82%,散户资金净流入2683.5万元,占总成交额13.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100008684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","BK0185","002589","BK0197","BK0132","BK0250"],"gpt_icon":0},{"id":"2489482740","title":"瑞康医药(002589)11月29日股东户数8.53万户,较上期减少2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489482740","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489482740?lang=zh_cn&edition=full","pubTime":"2024-12-05 17:04","pubTimestamp":1733389486,"startTime":"0","endTime":"0","summary":"证券之星消息,近日瑞康医药披露,截至2024年11月29日公司股东户数为8.53万户,较11月20日减少2529.0户,减幅为2.88%。在医药商业行业个股中,瑞康医药股东户数高于行业平均水平,截至11月29日,医药商业行业平均股东户数为3.98万户。从股价来看,2024年11月20日至2024年11月29日,瑞康医药区间跌幅为3.04%,在此期间股东户数减少2529.0户,减幅为2.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120500028154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002589","BK0077","BK0070","BK0197","BK0185","BK0250","BK0132"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746333098489,"stockEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0208},{"period":"3month","weight":0.065},{"period":"6month","weight":-0.0209},{"period":"1year","weight":0.109},{"period":"ytd","weight":-0.0067}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0087},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0217}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"瑞康医药集团股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"117926人(较上一季度减少0.29%)","perCapita":"11580股","listingDate":"2011-06-10","address":"山东省烟台市芝罘区凤鸣路103号13号楼","registeredCapital":"150471万元","survey":" 瑞康医药集团股份有限公司的主营业务包含药品、器械配送板块、体外诊断板块、数字医疗板块、医药物流板块、中医药板块五大业务板块。其主要产品和服务为药品和器械配送、体外诊断、数字医疗、医药物流、中医药。公司目前已发展成一家全国性药品、医疗器械流通行业的领军企业之一,在中国医药商业协会公布的最新一期医药流通企业销售排名第七。对医疗机构直销业务规模在全国民营医疗企业中处于领先地位,IVD业务规模在全国处于领先地位。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞康医药(002589)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞康医药(002589)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞康医药,002589,瑞康医药股票,瑞康医药股票老虎,瑞康医药股票老虎国际,瑞康医药行情,瑞康医药股票行情,瑞康医药股价,瑞康医药股市,瑞康医药股票价格,瑞康医药股票交易,瑞康医药股票购买,瑞康医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞康医药(002589)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞康医药(002589)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}